The minimally invasive catheterization technique known as prostatic artery embolization (PAE) is showing promise as an outpatient
treatment for patients suffering from the increasingly prevalent condition of prostate hyperplasia. Pioneered by a Brazilian radiologist
Prof C Carnevale, the procedure began U.S. Food and Drug Administration – approved trials last year in twelve medical centers
in the USA and Europe.